Agilent Solutions for Biopharmaceutical Analysis is the leading provider of analytical solutions to the biopharmaceutical industry. Agilent offers an extensive portfolio of end-to-end, workflow-driven solutions across key process development, scale-up, manufacturing and QA/QC applications.
Agilent provides a comprehensive portfolio of analytical solutions to help the biopharmaceutical industry bring biologics to market faster. The offerings span key areas including process development, scale-up, manufacturing, and quality control applications.
The document details specific technologies for physiochemical characterization, such as intact protein analysis, glycosylation studies, peptide mapping, and amino acid analysis. It also addresses product-related impurity analysis, contamination testing, and stability assessments using various chromatography and electrophoresis methods.
Agilent offers solutions across process development, scale-up, manufacturing, and quality control (QA/QC) applications.
Agilent provides robust analytical solutions using liquid chromatography, LC/MS, microfluidic electrophoresis devices, and size exclusion HPLC systems.
Agilent software solutions support GLP/GMP and 21 CFR Part 11 compliance with features like audit trails, multi-user login security, and electronic signatures.